GTBP logo

GT Biopharma Inc

GTBP

$3.91

- $188.29 (-97.94%) This month

Closed: 26 Feb 2024 21:00 US/Eastern

Key details

CEO

Anthony Cataldo

Employees

N/A

Headquarters

Westlake Village, US

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About GT Biopharma Inc

using our proprietary platform technology, gt biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute myeloid leukemia, myeloid dysplastic syndrome, and multiple solid tumors by leveraging our proprietary nk cell engager (trike) platform technology. (nasdaq: gtbp)

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG